ESR1 and breast carcinoma: In this study, utilizing an estrogen receptor-α (ERα) positive breast cancer cell line, MCF7, before (control) and after estrogen treatment (E2-treated) as a model system, we investigate these biological questions and address how E2 stimulation will affect chromatin interactions resulting in altering gene regulation and their relations with epigenetic modification states.